Clinical Trial Update: Pyronaridine-artesunate and Artemether-lumefantrine for the Treatment of Paediatric Malaria [Phase 3]

View source ↗

Summary

Phase 3 study evaluating the efficacy and safety of pyronaridine-artesunate and artemether-lumefantrine in paediatric malaria; trial completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Malaria

Drugs mentioned

• Artemether-lumefantrine (artemether and lumefantrine)
• Pyronaridine-artesunate (pyronaridine/artesunate)

Snippet

Sponsor: Royal Tropical Institute | Conditions: Malaria | Phase 3 | Status: COMPLETED